UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

Journal of cellular and molecular medicine, 2008-12, Vol.12 (6b), p.2552-2565

2008

Volltextzugriff (PDF)

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

Bone marrow transplantation (Basingstoke), 2016-11, Vol.51 (11), p.1524-1526

2016

Volltextzugriff (PDF)

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

British journal of cancer, 2024-05, Vol.130 (9), p.1529-1541

2024

Volltextzugriff (PDF)

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

Leukemia, 2009-04, Vol.23 (4), p.664-672

2009

Volltextzugriff (PDF)

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.684-690

2014

Volltextzugriff (PDF)

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

Investigational new drugs, 2019-02, Vol.37 (1), p.17-26

2019

Volltextzugriff (PDF)

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

Leukemia, 2008-06, Vol.22 (6), p.1250-1255

2008

Volltextzugriff (PDF)

LIGHT/HVEM/LTβR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation

American journal of transplantation, 2013-03, Vol.13 (3), p.541-551

2013

Volltextzugriff (PDF)

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.438-444

2017

Volltextzugriff (PDF)

Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.265-268

2013

Volltextzugriff (PDF)

RUNX1 amplification in AML with myelodysplasia‐related changes and ring 21 chromosomes

Hematological oncology, 2017-12, Vol.35 (4), p.894-899

2017

Volltextzugriff (PDF)

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

Leukemia, 2002-08, Vol.16 (8), p.1423-1431

2002

Volltextzugriff (PDF)

Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm

Diagnostic cytopathology, 2016-01, Vol.44 (1), p.39-40

2016

Volltextzugriff (PDF)

NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression

International journal of laboratory hematology, 2016-02, Vol.38 (1), p.64-71

2016

Volltextzugriff (PDF)

Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists

Climacteric : the journal of the International Menopause Society, 2024-06, Vol.27 (3), p.275-281

2024

Volltextzugriff (PDF)

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

Leukemia, 2006-03, Vol.20 (3), p.542-545

2006

Volltextzugriff (PDF)

Effect of vitamin D treatment in chronic GVHD

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1395-1397

2011

Volltextzugriff (PDF)

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.419-430

2020

Volltextzugriff (PDF)

Immunomodulatory effect of mesenchymal stem cells

Brazilian journal of medical and biological research, 2010-05, Vol.43 (5), p.425-430

2010

Volltextzugriff (PDF)

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma

Bone marrow transplantation (Basingstoke), 2006-06, Vol.37 (12), p.1135-1141

2006

Volltextzugriff (PDF)

Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1487-1488

2011

Volltextzugriff (PDF)

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning

Bone marrow transplantation (Basingstoke), 2003-03, Vol.31 (5), p.387-392

2003

Volltextzugriff (PDF)

Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study

Transplantation proceedings, 2011-06, Vol.43 (5), p.1934-1938

2011

Volltextzugriff (PDF)

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment

Leukemia research, 2012-07, Vol.36 (7), p.895-899

2012

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(305)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

LIGHT/HVEM/LTβR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients

RUNX1 amplification in AML with myelodysplasia‐related changes and ring 21 chromosomes

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm

NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression

Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists

Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

Effect of vitamin D treatment in chronic GVHD

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

Immunomodulatory effect of mesenchymal stem cells

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma

Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning

Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment

Suchergebnisse filtern